Genetic alterations in hepatocellular carcinomas: Association between loss of chromosome 4q and p53 gene mutations

British Journal of Cancer

Volumn 80, Issue 1-2, 1999, Pages 59-66

  Rashid, A ^a   Wang, J S ^d   Qian, G S ^b   Lu, B X ^c   Hamilton, S R ^a   Groopman, J D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c QIDONG LIVER CANCER INSTITUTE   (China)

^d NONE

Author keywords

Aflatoxin; Hepatitis B virus; Hepatocellular carcinomas; Loss of heterozygosity; p53 gene

Indexed keywords

PROTEIN P53;

ARTICLE; CHINA; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 1P; CHROMOSOME 4Q; CHROMOSOME LOSS; CLINICAL ARTICLE; CODON; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MICROSATELLITE INSTABILITY; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL;

EID: 0142199720     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690321     Document Type: Article

References (68)

1. 1 induces the transversion of G-T in codon 249 of the tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 90: 8586-8590
2. Bankfalvi A, Navabi H, Bier B, Bocker W, Jasani B and Schmid KW (1994) Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol 174: 223-228
3. Becker SA, Zhou Y-Z and Slagle BL (1996) Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 56: 5092-5097
4. Boige V, Laurent-Puig P, Fouchet P, Flejou JF, Monges G, Bedossa P, Bioulac-Sage P, Capron F, Schmitz A, Olschwang S and Thomas G (1997) Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res 57: 1986-1990
5. Bourdon J-C, D'Errico A, Paterlini P, Grigioni W, May E and Debuire B (1995) p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 108: 1176-1182
6. Bressac B, Kew M, Wands J and Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond) 350: 429-431
7. Brockmoller J, Kerb R, Drakoulis N, Nitz M and Roots I (1993) Genotype and phenotype of glutathione S-transferase class μ isoenzymes μ and ψ in lung cancer patients and control. Cancer Res 53: 1004-1011
8. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A and Govindarajah S (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86: 8852-8856
9. Chen H-L, Chen Y-C and Chen D-S (1998) Chromosome 1p aberrations are frequent in human primary hepatocellular carcinoma. Cancer Genet Cytogenet 86: 102-106
10. Comstock KE, Sanderson BJS, Claflin G and Henner WD (1990) GST1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res 18: 3670
11. Coursaget P, Depril N, Chabaud M, Nandi R, Mayelo V, LeCann P and Yvonnet B (1993) High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br J Cancer 67: 1395-1397
12. De Souza AT, Hankins GR, Washington MK, Orton TC and Jirtle RL (1995) M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet 11: 447-449
13. Devilee P, Vliet M, Bardoel A, Kievits T, Kuipers-Dijkshoon N, Pearson PL and Cornelisse CJ (1991) Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res 51: 1020-1025
14. Dohner H, Bloomfield CD, Frizzera G, Frestedt J and Arthur DC (1992) Recurring chromosome abnormalities in Hodgkin's disease. Genes Chromosom Cancer 5: 392-398
15. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE and Kefford RF (1989) Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 88: 4614-4618
16. Dumenco L, Oguey D, Wu J, Messier N and Fausto N (1995) Introduction of a murine p53 mutation corresponding to human codon 249 into a murine hepatocyte cell line results in growth advantage, but not in transformation. Hepatology 22: 1279-1288
17. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M and Nakamura Y (1992) Frequent loss of heterozygosity for loci on chromosome 8 p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 52: 5368-5372
18. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K and Nakamura Y (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51: 89-93
19. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL and Russell SHE (1997) Allelotype analysis of adenocarcinoma of the gastric cardia. Br J Cancer 76: 1455-1465
20. Greenblatt MS, Feitelson MA, Zhu M, Bennett WP, Welsh JA, Borkowski A and Harris CC (1997) Integrity of p53 in hepatitis B X antigen-positive and -negative hepatocellular carcinoma. Cancer Res 57: 426-432
21. Groopman JD, Wang J-S and Scholl P (1996) Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. Can J Physiol Pharmacol 74: 203-209
22. Hammoud ZT, Kaleem Z, Cooper JD, Sundaresan S, Patterson GA and Goodfellow PJ (1996) Alleotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequence on the long arm of chromosome 4. Cancer Res 56: 4499-4502
23. Hampton GM, Larson AA, Baergen RN, Sommers RL, Kern S and Cavenee WK (1996) Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci USA 93: 6704-6709
24. Hayashi H, Sugio K, Matsumata T, Adachi E, Takenaka K and Sugimachi K (1995) The clinical significance of p53 gene mutation in hepatocelluar carcinomas from Japan. Hepatology 22: 1702-1707
25. Henkler F, Waseem N, Golding MHC, Alison MR and Koshy R (1995) Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus related human hepatocellular carcinoma. Cancer Res 55: 6084-6091
26. Hsu H-C, Peng S-Y, Lai P-L, Sheu J-C, Chen D-S, Lin L-I, Slagle BL and Butel JS (1994) Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. Cancer 73: 42-47
27. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ and Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond) 350: 427-428
28. Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T and Harris CC (1993) p53 gene mutation and integrated hepatitis B viral DNA sequences in human cancer cell lines. Carcinogenesis (Lond) 14: 987-992
29. Inazawa J, Ariyama T, Abe T, Druck T, Ohta M, Huebner K, Yanagisawa J, Reed JC and Sato T (1996) PTPN13, a Fas-associated protein tyrosine phosphatase, is located on the long arm of chromosome 4 at band q21.3. Genomics 31: 240-242
30. Katagiri T, Nakamura Y and Miki Y (1996) Mutations in the BRCA2 gene in hepatocellular carcinomas. Cancer Res 56: 4575-4577
31. Kubicka S, Trautwein C, Schrem H, Tillmann H and Manns M (1995) Low incidence of p53 mutations in European hepatocellular carcinoma with heterogeneous mutation as a rare event. J Hepatol 23: 412-419
32. Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T and Nakamura Y (1995a) Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13 q. Br J Cancer 72: 383-385
33. Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T and Nakamura Y (1995b) Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosom Cancer 13: 163-167
34. Leister I, Weith A, Bruderlein S, Cziepluch C, Kangwanpong D, Schlag P and Schwab M (1990) Human colorectal cancer: high frequency of deletions at chromosome 1p35. Cancer Res 50: 7232-7235
35. Leon M and Kew MC (1996) Loss of heterozygosity in chromosome 4q12-q13 in hepatocellular carcinoma in Southern African blacks. Anticancer Res 16: 349-352
36. 1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis (Lond) 7: 1291-1297
37. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A and Dejean A (1997) Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosom Cancer 18: 59-65
38. 1. Proc Natl Acad Sci USA 92: 2384-2387
39. Mitra AB, Murty VVVS, Li RG, Pratap M, Luthra UK and Chaganti RSK (1994) Allelotype analysis of cervical carcinoma. Cancer Res 54: 4481-4487
40. Nagai H, Pineau P, Tiollais P, Buendia MA and Dejean A (1997) Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 14: 2927-2933
41. Nasarek A, Werner M, Nolte M, Klempnauer J and Georgii A (1995) Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study. Virchows Arch 427: 373-378
42. Nasir J, Theilmann JL, Chopra V, Jones AM, Walker D, Rasper DM, Vaillancourt JP, Hewitt JE, Nicholson DW and Hayden MR (1997) Localization of the cell death genes CPP32 and Mch-2 to human chromosome 4q. Mammalian Genome 8: 56-59
43. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR and Pereira-Smith OM (1991) Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 88: 5635-5639
44. Nose H, Imazeki F, Ohto M and Omata M (1993) p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer 72: 355-360
45. Ozturk M, Bressac B, Puisieux A, Kew M, Volkmann M, Bozcall S, Bella Mura J, de la Monte S, Carlson R, Blum H, Wands J, Takahashi H, von Weizsäcker F, Galun E, Siddhartha K, Carr BI, Schröder CH, Erken E, Varinli S, Rustgi VK, Prat J, Toda G, Koch HK, Liang XH, Tang Z-Y, Shouval D, Lee H-S, Vjas GN and Sarosi I (1991) p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338: 1356-1359.
46. Pershouse MA, El-Naggar AK, Hurr K, Lin H, Yung WKA and Steck PA (1997) Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene 14: 369-373
47. Polascik TJ, Cairns P, Chang WYH, Schoenberg MP and Sidransky D (1995) Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res 55: 5396-5399
48. Ponchel F, Puisieux A, Tabone E, Michot JP, Frosehl G, Morel AP, Frebourg T, Fontaniere B, Oberhammer F and Ozturk M (1994) Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor β1-mediated apoptosis. Cancer Res 54: 2064-2068
49. Qian G-S, Ross RK, Yu, MC, Yuan, J-M, Gao Y-T, Henderson BE, Wogan GN and Groopman JD (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3: 3-10
50. Rashid A and Hamilton SR (1997) Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 113: 127-135
51. Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ and Kern SE (1994) p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 54: 3025-3033
52. Shi CY, Phang TW, Lin Y, Wee A, Li B, Lee HP and Ong CN (1995) Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore. Br J Cancer 72: 146-149
53. Simon D, Knowles BB and Weith A (1991) Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6: 765-770
54. Slagle BL, Zhou Y-Z, Birchmeier W and Scorsone KA (1993) Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology 18: 757-762
55. Takahashi K, Kudo J, Ishibashi H, Hirata Y and Niho Y (1993) Frequent loss of heterozygosity on chromosome 22 in hepatocellulur carcinoma. Hepatology 17: 794-799
56. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T and Hirohashi S (1990) Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6791-6794
57. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA and Jay G (1995) Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genet 9: 41-47
58. Urano Y, Watanabe K, Lin CC, Hino O and Tamaoki T (1991) Interstitial chromosomal deletion within 4q11-q13 in a human hepatoma cell line. Cancer Res 51: 1460-1464
59. Verhaegh GWCT, Jongmans W, Jaspers NGJ, Natarajan AT, Oshimura M, Lohman PHM and Zdzienicka MZ (1995) A gene that regulates DNA replication in response to DNA damage is located on human chromosome 4q. Am J Hum Genet 57: 1095-1103
60. Walker GJ, Hayward NK, Falvey S and Cooksley WGE (1991) Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res 51: 4367-4370
61. Wang HP and Rogler CE (1988) Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet 48: 72-78
62. Weith A, Martinsson T, Cziepluch C, Bruderlein S, Amler LC, Berthold F and Schwab M (1989) Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosom Cancer 1: 159-166
63. Yeh S-H, Chen P-J, Chen H-L, Lai M-Y, Wang C-C and Chen D-S (1994) Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 54: 4188-4192
64. Yeh S-H, Chen P-J, Lai M-Y and Chen D-S (1996) Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated α-fetoprotein production. Gastroenterology 110: 184-192
65. Yu M-W and Chen C-J (1994) Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 17: 71-91
66. Yumoto Y, Hanafusa T, Hada H, Morita T, Ooguchi S, Shinji N, Mitani T, Hamaya K, Koide N and Tsuji T (1995) Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol 10: 179-185
67. Zhang W, Hirohashi S, Tsuda H, Shimosato Y, Yokota J, Terada M and Sugimura T (1990) Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 81: 108-111
68. Zhang X, Xu H-J, Murakami Y, Sachse R, Yashima K, Hirohashi S, Hu S-X, Benedict WF and Sekiya T (1994) Deletions of chromosome 13q. mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 54: 4177-4182